Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Purple Biotech(PPBT) the EBIT is -1.299 M (-5.1%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITExceed expectations
-0.00B5.10%
-0.00B94.17%
+0.00B89.07%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf